RESUMO
BACKGROUND: Dengue is an acute febrile illness caused by an arbovirus that is endemic in more than 100 countries. Early diagnosis and adequate management are critical to reduce mortality. This study aims to identify clinical and hematological features that could be useful to discriminate dengue from other febrile illnesses (OFI) up to the third day of disease. METHODS: We conducted a sectional diagnostic study with patients aged 12 years or older who reported fever lasting up to three days, without any evident focus of infection, attending an outpatient clinic in the city of Rio de Janeiro, Brazil, between the years 2005 and 2008. Logistic regression analysis was used to identify symptoms, physical signs, and hematological features valid for dengue diagnosis. Receiver-operating characteristic (ROC) curve analyses were used to define the best cut-off and to compare the accuracy of generated models with the World Health Organization (WHO) criteria for probable dengue. RESULTS: Based on serological tests and virus genome detection by polymerase chain reaction (PCR), 69 patients were classified as dengue and 73 as non-dengue. Among clinical features, conjunctival redness and history of rash were independent predictors of dengue infection. A model including clinical and laboratory features (conjunctival redness and leukocyte counts) achieved a sensitivity of 81% and specificity of 71% and showed greater accuracy than the WHO criteria for probable dengue. CONCLUSIONS: We constructed a predictive model for early dengue diagnosis that was moderately accurate and performed better than the current WHO criteria for suspected dengue. Validation of this model in larger samples and in other sites should be attempted before it can be applied in endemic areas.
Assuntos
Dengue/diagnóstico , Febre/diagnóstico , Adulto , Diagnóstico Diferencial , Testes Diagnósticos de Rotina , Feminino , Humanos , Masculino , Razão de Chances , Curva ROC , Fatores de Tempo , Adulto JovemRESUMO
The present study investigated the diagnostic value of polymerase chain reaction (PCR) performed in parallel to conventional methods at an American tegumentary leishmaniasis (ATL) referral centre for diagnosis. Accuracy parameters for PCR were calculated using 130 patients with confirmed ATL (ATL group), 15 patients established with other diseases and 23 patients with a lesion suggestive of ATL, but without parasitological confirmation (NDEF group). PCR showed 92.3% sensitivity, 93.3% specificity, a 99.2% positive predictive value and a 13.84 positive likelihood ratio. In the NDEF group, PCR confirmed ATL in 13 of the 23 patients, seven of whom responded to leishmaniasis treatment and six who presented spontaneous healing of the lesion. PCR should be included in the routine diagnostic procedures for ATL, especially for cases found to be negative by conventional methods.
Assuntos
DNA de Protozoário/análise , Leishmania/genética , Leishmaniose Cutânea/diagnóstico , Reação em Cadeia da Polimerase , Humanos , Leishmaniose Cutânea/parasitologia , Valor Preditivo dos Testes , Sensibilidade e EspecificidadeRESUMO
The objective of the present study was to evaluate the specificity of the Montenegro skin test (MST) in an area in Brazil, state of Grande do Sul State (RS), which was considered to be non-endemic for leishmaniasis. Sixty subjects presented a positive MST and were reevaluated by clinical examination, serology and polymerase chain reaction (PCR) of peripheral blood for the detection of subclinical Leishmania infection. None of the subjects presented clinical signs or symptoms of current leishmaniasis or a history of the disease.Leishmania (Viannia) DNA was detected in blood by PCR and hybridization in one subject. The PCR skin test-positive individual remained asymptomatic throughout the study. Clinical examination showed no scars suggestive of past cutaneous leishmaniasis. Human subclinical infection with Leishmania (Viannia) in RS was confirmed by PCR. This is the first report of subclinical infection with this parasite in the human population of this area.
Assuntos
Animais , Humanos , Leishmania braziliensis , Leishmaniose Cutânea/diagnóstico , Estudos de Casos e Controles , DNA de Protozoário/sangue , Leishmania braziliensis/genética , Leishmania braziliensis/imunologia , Leishmaniose Cutânea/parasitologia , Reação em Cadeia da Polimerase , Sensibilidade e Especificidade , Testes Cutâneos/métodosRESUMO
The objective of the present study was to evaluate the specificity of the Montenegro skin test (MST) in an area in Brazil, state of Grande do Sul State (RS), which was considered to be non-endemic for leishmaniasis. Sixty subjects presented a positive MST and were reevaluated by clinical examination, serology and polymerase chain reaction (PCR) of peripheral blood for the detection of subclinical Leishmania infection. None of the subjects presented clinical signs or symptoms of current leishmaniasis or a history of the disease. Leishmania (Viannia) DNA was detected in blood by PCR and hybridization in one subject. The PCR skin test-positive individual remained asymptomatic throughout the study. Clinical examination showed no scars suggestive of past cutaneous leishmaniasis. Human subclinical infection with Leishmania (Viannia) in RS was confirmed by PCR. This is the first report of subclinical infection with this parasite in the human population of this area.
Assuntos
Leishmania braziliensis , Leishmaniose Cutânea/diagnóstico , Animais , Estudos de Casos e Controles , DNA de Protozoário/sangue , Humanos , Leishmania braziliensis/genética , Leishmania braziliensis/imunologia , Leishmaniose Cutânea/parasitologia , Reação em Cadeia da Polimerase , Sensibilidade e Especificidade , Testes Cutâneos/métodosRESUMO
Concentra-se sobre a origem, difusäo e história das leishmanioses tegumentares americanas (LTA), com especial enfoque sobre a leishmaniose mucosa (LM) no continente sul-americano, cuja análise foi feita através de fontes históricas. (AU)
Assuntos
Leishmaniose Cutânea/história , Leishmaniose Mucocutânea/história , Indígenas Sul-Americanos , Peru , Bolívia , Brasil , Doenças Transmissíveis/históriaRESUMO
Concentra-se sobre a origem, difusão e história das leishmanioses tegumentares americanas (LTA), com especial enfoque sobre a leishmaniose mucosa (LM) no continente sul-americano, cuja análise foi feita através de fontes históricas.
Assuntos
Leishmaniose Cutânea/história , Leishmaniose Mucocutânea/história , Bolívia , Brasil , Doenças Transmissíveis/história , PeruRESUMO
Drawing from four sixteenth-century sources, the article reports some apparent incidents of American Tegumentary Leishmaniasis within the territory of the Andes. Reinterpretation of these sources affords a look at the longstanding issue of the origin of espundia,or mucosal Leishmaniasis (ML). The study reinforces the hypothesis that ML originated in the western Amazon region, from there climbing into the high forests and later into hot inter-Andean lands via Bolivia's and Peru's borders with Brazil, above al through human migration. dating to archeological times, this process intensified during the Inca period under the social policies of the mitmaq or mitimaes. These events transpired within the historical and social context of the fall of the Inca Empire and the advent of Spanish colonization.
Assuntos
Leishmaniose Cutânea/história , Paleopatologia/história , História Antiga , História Pré-Moderna 1451-1600 , História Medieval , América do SulRESUMO
Aborda e discute a questäo da epidemia da filariose linfática e revisa o histórico de seu controle desde sua notificaçäo, em 1952, por Rachou, até nossos dias. Hoje, apenas na regiäo metropolitana do Recife e de Belém, esta endemia é considerada um problema de saúde pública.(JGC)
Assuntos
Filariose Linfática/prevenção & controle , Saúde Pública/história , Brasil , História da Medicina , Política de Saúde/históriaRESUMO
A phase 1 double-blind placebo-controlled study was performed to evaluate a vaccine against American tegumentary leishmaniasis in 61 healthy male volunteers. Side effects and the immune response to the vaccine were evaluated, with 1- and 2- dose schemes, with intervals of 7 or 21 days, each dose containing 1440 mg of protein N antigen of a single strain of Leishmania amazonensis (PH 8) diluted in merthiolated saline (1:10,000). Merthiolated saline and an inert substance were used as placebos. No significant clinical alterations were found following the respective injections in the vaccinated individuals as compared to the placebos, except for local pain, which was associated significantly with injection of the vaccine. The laboratory alterations we observed bore no association with the clinical findings and were unimportant. We observed no differences between the groups with regard to seroconversion or the Montenegro skin test. However, the group that received a single dose of the vaccine and the one that received two doses with a 21-day interval displayed cutaneous induration significantly larger than in the control group, with 100 per cent and 66 per cent conversion in the skin test, respectively. We concluded that the vaccine does not present any major side effect that would contraindicate its use in healthly individuals.
Assuntos
Humanos , Masculino , Leishmaniose Cutânea/imunologia , Vacinas , Leishmania/imunologiaRESUMO
Laboratory studies were carried out on 3178 patients with signs and symptoms suggestive of dengue infection from April 1986 to December 1987 in the State of Rio de Janeiro, Brazil. The epidemic had two peaks following the first virus isolation and affected the inhabitants of 17 counties. Both sex and all age groups were affected. Dengue virus type 1 was isolated from 1039 sera and the number of confirmed cases was increased to 1874 (59) by MAC-ELISA. Isolation rate confirmed cases reached 80 in the specimens obtained until the 4th day after the onset of disease and viraemia ranged from 10(3.0) to 10(8.5) TCID50/ml.